Xiaoguang Li Selected Research

Xiaoguang Li Research Topics

Disease

61	Neoplasms (Cancer) 01/2022 - 11/2003
13	Bullous Pemphigoid (Pemphigoid) 07/2022 - 04/2014
9	Infections 01/2022 - 12/2007
8	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 01/2011
8	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 12/2010
5	COVID-19 01/2022 - 05/2020
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2016
5	Adenocarcinoma of Lung 01/2022 - 01/2020
5	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2017
4	Liver Neoplasms (Liver Cancer) 10/2021 - 08/2017
4	Cataract (Cataracts) 02/2021 - 01/2018
4	Fibrosis (Cirrhosis) 01/2021 - 11/2014
4	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2013
4	Inflammation (Inflammations) 06/2019 - 06/2014
4	Carcinogenesis 01/2018 - 11/2003
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 01/2017
3	Pneumonia (Pneumonitis) 04/2022 - 01/2015
3	Human Influenza (Influenza) 12/2021 - 01/2021
3	Squamous Cell Carcinoma of Head and Neck 10/2021 - 03/2020
3	Skin Diseases (Skin Disease) 05/2021 - 08/2013
3	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2013
3	Pemphigus (Pemphigus Vulgaris) 01/2021 - 03/2014
3	Carcinoma (Carcinomatosis) 03/2020 - 02/2015
3	Spinal Cord Injuries (Spinal Cord Injury) 04/2019 - 02/2009
3	Hemorrhage 01/2019 - 02/2014
3	Pain (Aches) 02/2010 - 06/2004
2	Insulin Resistance 01/2022 - 11/2002
2	Weight Loss (Weight Reduction) 01/2022 - 12/2007
2	Margins of Excision 07/2021 - 01/2021
2	Lymphoma (Lymphomas) 01/2021 - 06/2013
2	Disease Progression 01/2021 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2019
2	Reperfusion Injury 01/2020 - 03/2011
2	Pneumothorax 01/2020 - 06/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 03/2011
2	Neuralgia (Stump Neuralgia) 11/2019 - 06/2011
2	Hyperalgesia 11/2019 - 06/2011
2	Dehydration (Water Stress) 06/2019 - 09/2013
2	Hematoma 01/2019 - 07/2010
2	Atrophy 06/2018 - 12/2007
2	Memory Disorders (Memory Loss) 11/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2015
9	Laminin (Merosin)IBA 07/2022 - 02/2015
8	AutoantibodiesIBA 01/2022 - 03/2014
7	AntigensIBA 12/2021 - 05/2014
7	Pharmaceutical PreparationsIBA 01/2020 - 10/2016
6	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2010
6	AntibodiesIBA 01/2022 - 08/2014
6	EnzymesIBA 01/2017 - 03/2011
5	Biological ProductsIBA 02/2021 - 01/2011
5	Capsules (Microcapsules)IBA 01/2021 - 11/2014
5	Amyloid (Amyloid Fibrils)IBA 11/2017 - 12/2010
4	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 06/2022 - 01/2017
4	IntegrinsIBA 01/2022 - 11/2003
4	AutoantigensIBA 01/2022 - 06/2016
4	Messenger RNA (mRNA)IBA 10/2021 - 11/2014
4	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2014
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 01/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 04/2014
3	Immunoglobulin G (IgG)IBA 01/2022 - 09/2015
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	MicroRNAs (MicroRNA)IBA 10/2021 - 03/2015
3	artemisinin (artemisinine)IBA 02/2021 - 12/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2014
3	CollagenIBA 04/2019 - 11/2014
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018 - 01/2010
2	COVID-19 VaccinesIBA 01/2022 - 10/2021
2	Interferon Type IIBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2019
2	Therapeutic UsesIBA 02/2021 - 08/2017
2	Melphalan (Alkeran)FDA LinkGeneric 02/2021 - 12/2016
2	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2020
2	AlkaloidsIBA 01/2021 - 01/2011
2	kushenIBA 01/2021 - 01/2020
2	AerosolsIBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 08/2017
2	p38 Mitogen-Activated Protein KinasesIBA 10/2019 - 03/2014
2	Vitamin D FDA LinkGeneric 08/2019 - 01/2013
2	Hyaluronic Acid (Hyaluronan)IBA 04/2019 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 03/2019 - 05/2017
2	arseniteIBA 01/2019 - 10/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 11/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2013
2	NAD (NADH)IBA 01/2019 - 08/2015
2	ChitosanIBA 01/2019 - 02/2009
2	Oxidoreductases (Dehydrogenase)IBA 01/2019 - 12/2010
2	Indicators and Reagents (Reagents)IBA 01/2018 - 10/2014
2	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2018 - 01/2018

Therapy/Procedure

25	Therapeutics 05/2021 - 10/2002
7	Aftercare (After-Treatment) 07/2021 - 09/2011
7	Drug Therapy (Chemotherapy) 01/2021 - 02/2015
3	Immunotherapy 10/2021 - 01/2021
3	Radiofrequency Ablation 02/2018 - 01/2015
2	Salvage Therapy 01/2021 - 01/2020
2	Debridement 01/2021 - 09/2011
2	Cesarean Section (Caesarean Section) 08/2020 - 08/2019
2	Radiotherapy 03/2020 - 01/2018